P. Barton Duell
About
P. Barton Duell is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, P. Barton Duell has authored 114 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Surgery, 37 papers in Endocrinology, Diabetes and Metabolism and 24 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P. Barton Duell's work include Lipoproteins and Cardiovascular Health (54 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers) and Lipid metabolism and disorders (20 papers). P. Barton Duell is often cited by papers focused on Lipoproteins and Cardiovascular Health (54 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers) and Lipid metabolism and disorders (20 papers). P. Barton Duell collaborates with scholars based in United States, Canada and United Kingdom. P. Barton Duell's co-authors include William E. Connor, Bruce A. Warden, Barbara Upson, M.R. Malinow, David L. Hess, Glenn Gerhard, Patrick M. Moriarty, Warren D. Kruger, Peter C. Block and John F. Oram and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.
In The Last Decade
P. Barton Duell
110 papers receiving 4.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| P. Barton Duell United States | 33 | 2.6k | 1.0k | 930 | 745 | 619 | 114 | 4.7k | ||
| Kirsten B. Holven Norway | 37 | 1.4k 0.5× | 700 0.7× | 327 0.4× | 611 0.8× | 707 1.1× | 195 | 4.1k | ||
| Ioanna Gouni‐Berthold Germany | 37 | 4.1k 1.6× | 1.8k 1.8× | 234 0.3× | 1.6k 2.2× | 1.2k 1.9× | 156 | 7.5k | ||
| Ulrich Julius Germany | 28 | 1.5k 0.6× | 1.5k 1.5× | 209 0.2× | 735 1.0× | 548 0.9× | 173 | 3.6k | ||
| James A. Bolognese United States | 31 | 1.3k 0.5× | 265 0.3× | 798 0.9× | 1.1k 1.5× | 658 1.1× | 71 | 5.7k | ||
| Theodosios D. Filippatos Greece | 41 | 1.9k 0.7× | 2.3k 2.2× | 228 0.2× | 722 1.0× | 998 1.6× | 142 | 4.8k | ||
| Paolo Rubba Italy | 34 | 1.7k 0.7× | 1.1k 1.1× | 529 0.6× | 2.0k 2.7× | 302 0.5× | 151 | 4.6k | ||
| Patrick M. Moriarty United States | 35 | 3.1k 1.2× | 1.3k 1.2× | 186 0.2× | 1.3k 1.7× | 737 1.2× | 109 | 4.8k | ||
| R Češka Czechia | 28 | 3.4k 1.3× | 1.3k 1.2× | 148 0.2× | 1.1k 1.4× | 598 1.0× | 174 | 4.8k | ||
| Joseph P. McConnell United States | 42 | 3.0k 1.2× | 1.4k 1.4× | 372 0.4× | 2.0k 2.8× | 1.4k 2.3× | 109 | 7.9k | ||
| Genovefa Kolovou Greece | 34 | 1.4k 0.5× | 1.4k 1.4× | 524 0.6× | 1.8k 2.4× | 681 1.1× | 247 | 4.6k |
Countries citing papers authored by P. Barton Duell
Since
Specialization
Citations
This map shows the geographic impact of P. Barton Duell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Barton Duell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Barton Duell more than expected).
Fields of papers citing papers by P. Barton Duell
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by P. Barton Duell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Barton Duell. The network helps show where P. Barton Duell may publish in the future.
Co-authorship network of co-authors of P. Barton Duell
This figure shows the co-authorship network connecting the top 25 collaborators of P. Barton Duell. A scholar is included among the top collaborators of P. Barton Duell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Barton Duell. P. Barton Duell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Saadatagah, Seyedmohammad, Mohammadreza Naderian, Vijay Nambi, et al.. (2025). Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology. American Journal of Preventive Cardiology. 22. 100978–100978.
2.
Warden, Bruce A. & P. Barton Duell. (2025). Real-world evaluation of bempedoic acid use in patients with homozygous familial hypercholesterolemia. Journal of clinical lipidology. 20(1). 96–103.
3.
Duell, P. Barton, Maciej Banach, Alberico L. Catapano, et al.. (2024). Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials. Journal of clinical lipidology. 18(2). e153–e165.
4.
Mahajan, Kunal, Raman Puri, P. Barton Duell, et al.. (2024). Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study. Journal of clinical lipidology. 18(5). e867–e872.
5.
Raal, Frederick J., Robert S. Rosenson, Laurens F. Reeskamp, et al.. (2023). The Long-Term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia. JACC Advances. 2(9). 100648–100648.
6.
Goldberg, Anne C., Maciej Banach, Alberico L. Catapano, et al.. (2023). Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials. Atherosclerosis. 384. 117192–117192.
7.
Stroes, Erik S.G., Harold Bays, Maciej Banach, et al.. (2023). Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials. Atherosclerosis. 373. 1–9.
8.
Leiter, Lawrence A., Maciej Banach, Alberico L. Catapano, et al.. (2022). Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials. Diabetes Obesity and Metabolism. 24(5). 868–880.
9.
Warden, Bruce A., John R. Guyton, Laney K. Jones, et al.. (2022). Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association. Journal of clinical lipidology. 17(1). 19–39.
10.
Hauser, Stefan, Eylan Yutuc, Holger Hengel, et al.. (2021). Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis. Journal of Lipid Research. 62. 100078–100078.
11.
Warden, Bruce A., Carlota Oleaga, Om P. Ganda, et al.. (2020). Unusual Responses to PCSK9 Inhibitors in a Real-world Clinical Cohort. SHILAP Revista de lepidopterología. 3. 100042–100042.
12.
Warden, Bruce A., Jessica Minnier, P. Barton Duell, Sergio Fazio, & Michael D. Shapiro. (2020). Chylomicronemia syndrome: Familial or not?. Journal of clinical lipidology. 14(2). 201–206.
13.
Brown, Emily, Amy C. Sturm, Marina Cuchel, et al.. (2020). Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association. Journal of clinical lipidology. 14(4). 398–413.
14.
Leiter, Lawrence A., Maciej Banach, Alberico L. Catapano, et al.. (2019). Abstract 11417: Bempedoic Acid and Glycemic Control: A Pooled Analysis of 4 Phase 3 Clinical Trials. Circulation.
15.
Reeskamp, Laurens F., John J.P. Kastelein, Patrick M. Moriarty, et al.. (2018). Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis. 280. 109–117.
16.
Abdel‐Khalik, Jonas, Peter J. Crick, Eylan Yutuc, et al.. (2018). Identification of 7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acids in human cerebrospinal fluid and plasma. Biochimie. 153. 86–98.
17.
Wilson, Leah M., R. J. Cross, & P. Barton Duell. (2017). Reduced psychological distress in familial chylomicronemia syndrome after patient support group intervention. Journal of clinical lipidology. 12(1). 240–242.
18.
Wang, Yingming, D. Roger Illingworth, Sonja L. Connor, P. Barton Duell, & William E. Connor. (2010). Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene. European Journal of Nutrition. 49(6). 327–336.
19.
Weidner, Gerdi, Sonja L. Connor, Glenn Gerhard, P. Barton Duell, & William E. Connor. (2009). The effects of dietary cholesterol-lowering on psychological symptoms: A randomised controlled study. Psychology Health & Medicine. 14(3). 255–261.
20.
Duell, P. Barton. (1996). Prevention of Atherosclerosis with Dietary Antioxidants: Fact or Fiction?. Journal of Nutrition. 126(4 Suppl). 1067S–1071S.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kirsten B. Holven Breakdown of academic impact, for papers by Ioanna Gouni‐Berthold Breakdown of academic impact, for papers by Ulrich Julius Breakdown of academic impact, for papers by James A. Bolognese Breakdown of academic impact, for papers by Theodosios D. Filippatos Breakdown of academic impact, for papers by Paolo Rubba Breakdown of academic impact, for papers by Patrick M. Moriarty Breakdown of academic impact, for papers by R Češka Breakdown of academic impact, for papers by Joseph P. McConnell Breakdown of academic impact, for papers by Genovefa Kolovou